panniculitis: a group of diseases whose hallmark is inflammation of subcutaneous adipose tissue (the fatty layer under the skin - panniculus adiposus). Symptoms include tender skin nodules, and systemic signs such as weight loss and fatigue.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
399 |
4. Check minimum number of eventsNone |
399 |
5. Include endpointsNone |
399 |
6. Filter based on genotype QC (FinnGen only) |
381 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M79
- Name in latin
- Panniculitis non specificata
Similar endpoints
↥List of similar endpoints to
Panniculitis, unspecified
based on the number of shared cases.
Similar with more cases:
- Other soft tissue disorders, not elsewhere classified
- Soft tissue disorders
- Pain (limb, back, neck, head abdominally)
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2209 | 1489 | 709 |
| Only index persons | 2001 | 1370 | 631 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 58.09 | 58.14 | 57.96 |
| Only index persons | 57.31 | 57.27 | 57.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 381 | 256 | 125 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | 57.68 | 55.42 | 62.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 399
- Matched controls
- 3990
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M79.3
ICD-10 Finland
Panniculitis, unspecified
+∞
307.7
387
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.7
78.9
122
193
L52
ICD-10 Finland
Erythema nodosum
97.3
47.1
51
6
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
6.2
44.0
87
172
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.3
34.4
79
177
P01BA02
ATC
hydroxychloroquine; oral
6.0
34.4
68
133
M79.6
ICD-10 Finland
Pain in limb
3.4
31.6
190
842
H02AB06
ATC
prednisolone; systemic
3.3
30.5
240
1243
A46
ICD-10 Finland
Erysipelas
4.1
29.2
97
290
TQW80
NOMESCO Finland
Local dermatologic skincare
9.5
28.5
35
40
N02AX02
ATC
tramadol; systemic, rectal
3.2
28.2
208
1024
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
26.5
156
670
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
25.5
223
1188
M13.9
ICD-10 Finland
Arthritis, unspecified
5.5
24.7
51
103
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.1
23.9
75
213
L04AX01
ATC
azathioprine; systemic
7.1
23.4
37
57
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.9
22.9
178
878
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
22.6
86
279
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.4
22.6
99
352
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.2
22.2
112
433
N03AX12
ATC
[U] gabapentin; oral
3.6
22.2
86
282
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
21.9
73
216
D07AC01
ATC
betamethasone; topical
2.7
21.3
184
949
E66.8
ICD-10 Finland
Other obesity
5.5
21.2
43
85
D07AD01
ATC
clobetasol; topical
3.3
21.1
100
372
L04AX03
ATC
methotrexate; systemic
4.0
20.8
65
183
N03AX16
ATC
[U] pregabalin
3.0
20.1
113
462
M79.0
ICD-10 Finland
Rheumatism, unspecified
42.4
19.7
24
6
C03CA01
ATC
furosemide; systemic
2.7
19.3
146
698
J01MA02
ATC
ciprofloxacin; systemic
2.5
17.7
177
960
A02BC02
ATC
pantoprazole; systemic
2.7
17.6
292
2001
J01FF01
ATC
clindamycin; systemic
2.7
17.6
132
624
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.0
17.1
52
143
M67.4
ICD-10 Finland
Ganglion
6.6
17.0
28
45
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.3
16.9
74
260
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.4
16.6
44
109
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
15.1
16.6
27
19
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
16.4
108
476
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
5.2
16.2
35
73
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.4
16.1
64
211
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.9
16.0
93
383
X59
ICD-10 Finland
Exposure to unspecified factor
2.9
15.9
87
347
UJF32
NOMESCO Finland
Coloscopy
2.6
15.9
124
594
7293X
ICD-9 Finland
Other disorders of soft tissues, Panniculitis, unspecified[PANNICULITIS NUD]
+∞
15.7
15
*
M79.1
ICD-10 Finland
Myalgia
3.3
15.5
65
222
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.7
15.2
52
155
L01BA01
ATC
methotrexate; systemic
6.6
15.2
25
40
S18
ICPC
Laceration/cut
2.3
15.2
198
1188
ZXA05
NOMESCO Finland
Left side
2.5
14.4
113
539
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
14.4
159
885
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
14.3
181
1065
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.4
14.3
126
634
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.0
14.2
42
113
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
11.0
13.9
26
25
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.3
13.9
59
202
M01AH05
ATC
etoricoxib; oral
2.3
13.9
255
1741
S97
ICPC
Chronic ulcer skin
4.1
13.8
40
106
M79.7
ICD-10 Finland
Fibromyalgia
15.4
13.7
22
15
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.5
13.7
35
84
T90
ICPC
Diabetes non-insulin dependent
2.5
13.7
112
543
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
13.6
101
468
M76.6
ICD-10 Finland
Achilles tendinitis
5.3
13.6
28
56
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.7
13.5
86
369
R50.9
ICD-10 Finland
Fever, unspecified
2.8
13.5
78
319
J01DB01
ATC
cefalexin; oral
3.0
13.4
343
2692
E0000UV, ,
ATC
2.2
13.4
187
1137
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
13.4
174
1028
SPAT1153
SPAT
Removal of sutures
2.3
13.3
137
735
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.2
13.2
57
197
M25.5
ICD-10 Finland
Pain in joint
2.3
13.2
132
699
L17
ICPC
Foot/toe symptom/complaint
2.3
13.2
128
669
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.6
13.1
88
388
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.7
13.0
43
125
J01MA12
ATC
levofloxacin; systemic
2.6
12.9
90
404
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
12.7
50
163
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
72.2
12.7
14
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.1
12.4
58
210
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.1
12.4
22
38
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
12.4
60
222
B01AB05
ATC
enoxaparin; parenteral
2.2
12.4
144
809
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
5.9
12.1
22
39
N06AX21
ATC
duloxetine; oral
3.1
12.0
55
197
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.1
11.9
21
36
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.9
11.9
62
239
UJF30
NOMESCO Finland
Ileoscopy through colon
3.1
11.8
54
193
SPAT1263
SPAT
Sampling
2.1
11.8
179
1110
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.9
11.7
35
95
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
9.7
11.7
23
25
E000001, ,
ATC
2.4
11.7
93
443
J01DA01
ATC
[U] cefalexin
2.1
11.5
255
1814
M02AA07
ATC
piroxicam; topical
2.1
11.4
149
870
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.1
11.4
24
49
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.2
11.1
113
597
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.3
10.9
29
72
R03AC02
ATC
salbutamol; inhalant
2.0
10.8
228
1581
P01AB01
ATC
metronidazole; oral, rectal
2.0
10.6
173
1091
ZXA00
NOMESCO Finland
Right side
2.2
10.6
115
623
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.6
10.5
20
37
H02AB04
ATC
methylprednisolone; systemic
2.6
10.5
69
299
N06AA09
ATC
amitriptyline; systemic
3.1
10.5
47
166
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.4
10.5
40
128
A18.4
ICD-10 Finland
Tuberculosis of skin and subcutaneous tissue
+∞
10.5
10
*
M05BA04
ATC
alendronic acid; oral
3.0
10.4
48
172
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.7
10.4
34
98
SPAT1262
SPAT
Handing over of treatment supplies
2.4
10.4
81
380
R60.0
ICD-10 Finland
Localized oedema
2.8
10.4
55
213
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
33.5
10.4
13
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
10.3
107
567
M48.0
ICD-10 Finland
Spinal stenosis
2.9
10.3
51
191
M54.5
ICD-10 Finland
Low back pain
2.1
10.2
135
786
A02BC05
ATC
esomeprazole; systemic
2.0
10.2
166
1044
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
8.5
10.0
21
26
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
5.3
9.9
20
39
R42
ICD-10 Finland
Dizziness and giddiness
2.2
9.9
101
531
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
4.7
9.9
23
51
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
9.8
115
639
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
9.7
94
483
WX002
NOMESCO Finland
Sedation and analgesia
2.3
9.7
84
413
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.8
9.6
30
84
AA1AD
NOMESCO Finland
CT of head and brain
2.1
9.6
112
621
103
Kela drug reimbursment
Diabetes, insulin-treated
2.1
9.6
117
660
L16
ICPC
Ankle symptom/complaint
2.8
9.5
51
199
M75.3
ICD-10 Finland
Calcific tendinitis of shoulder
30.8
9.5
12
*
R52.2
ICD-10 Finland
Other chronic pain
5.1
9.4
20
41
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
9.0
9.4
19
22
M54.4
ICD-10 Finland
Lumbago with sciatica
2.4
9.3
70
322
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
9.3
52
207
NF1AA
NOMESCO Finland
Hip X-ray examination
3.1
9.3
41
143
M01AH01
ATC
celecoxib; oral
2.4
9.3
75
357
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.0
9.2
43
155
L14
ICPC
Leg/thigh symptom/complaint
3.1
9.2
39
133
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
9.2
42
150
R51.80
ICD-10 Finland
Headache
2.4
9.2
69
318
M01AC06
ATC
meloxicam; systemic, rectal
2.0
9.1
150
938
SPAT1255
SPAT
Intravenous administration of medicine
3.5
9.1
32
97
A02BC01
ATC
omeprazole; systemic
2.1
9.1
114
648
H02AB07
ATC
prednisone; oral
2.5
9.0
61
267
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
9.0
73
347
M54.3
ICD-10 Finland
Sciatica
3.7
9.0
29
83
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
7.1
9.0
21
31
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.4
8.9
67
308
R06.0
ICD-10 Finland
Dyspnoea
2.1
8.9
105
582
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.8
8.9
46
176
D64.9
ICD-10 Finland
Anaemia, unspecified
2.8
8.9
48
188
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
8.8
76
371
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.9
8.8
26
70
L88
ICD-10 Finland
Pyoderma gangrenosum
51.1
8.7
10
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.3
8.6
33
106
R60.9
ICD-10 Finland
Oedema, unspecified
3.7
8.6
27
76
M54.1
ICD-10 Finland
Radiculopathy
4.5
8.5
21
49
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
8.5
148
939
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.1
8.5
23
58
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.1
8.5
23
58
N02BE01
ATC
paracetamol; systemic, rectal
2.6
8.4
356
3040
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
8.4
48
194
L28
ICPC
Limited function/disability (L)
2.3
8.3
70
338
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
8.3
114
666
A01AB09
ATC
miconazole; local oral
2.8
8.3
42
159
SPAT1229
SPAT
Assessment of need for aid
3.2
8.3
34
114
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
8.2
99
552
L15
ICPC
Knee symptom/complaint
2.1
8.1
97
539
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
8.0
178
1214
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.3
8.0
31
100
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
2.5
8.0
51
217
J01FA06
ATC
roxithromycin; oral
1.9
8.0
161
1066
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
8.0
42
162
R10.0
ICD-10 Finland
Acute abdomen
4.6
8.0
19
43
ZXD05
NOMESCO Finland
Urgent procedure
1.9
8.0
124
755
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
7.9
102
582
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
7.9
67
325
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
7.8
39
146
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.3
7.8
20
48
L29
ICPC
Musculoskeletal sympt/complt other
2.9
7.8
37
135
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
7.7
40
153
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.6
7.7
25
72
M01AX17
ATC
nimesulide; oral
2.0
7.7
94
526
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.1
7.7
81
429
N02AA05
ATC
oxycodone; systemic
2.2
7.6
71
357
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
18.8
7.6
11
6
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
9.1
7.6
15
17
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
10.3
7.6
14
14
A10AE04
ATC
insulin glargine; parenteral
2.6
7.6
46
191
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.1
7.6
32
109
M01AX01
ATC
nabumetone; oral
3.8
7.6
23
63
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
7.5
59
276
M04AA01
ATC
allopurinol; systemic
2.4
7.5
54
243
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.9
7.5
22
59
L04AA06
ATC
mycophenolic acid; systemic
7.9
7.5
16
21
A01AB04
ATC
amphotericin B; local oral
3.5
7.4
26
79
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
7.4
79
420
L08
ICPC
Shoulder symptom/complaint
2.1
7.3
75
393
C07AB07
ATC
bisoprolol; oral
1.8
7.2
192
1370
M70.6
ICD-10 Finland
Trochanteric bursitis
2.5
7.2
49
215
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.2
7.2
29
96
A10BK03
ATC
empagliflozin; oral
2.5
7.2
46
196
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
30.6
7.2
9
*
G72.9
ICD-10 Finland
Myopathy, unspecified
30.6
7.2
9
*
M01CB01
ATC
sodium aurothiomalate; parenteral
12.3
7.1
12
10
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.8
7.1
36
136
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
10.3
7.1
13
13
WX320
NOMESCO Finland
Spinalanesthesy
2.0
7.0
97
564
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
7.0
29
98
K10.3
ICD-10 Finland
Alveolitis of jaws
3.5
6.9
24
72
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.7
6.9
39
156
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.9
6.9
20
53
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.9
6.9
20
53
D07AC13
ATC
mometasone; topical
1.8
6.9
121
762
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.9
6.8
32
116
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
6.8
43
182
J04BA02
ATC
dapsone; oral
17.1
6.8
10
6
Z01.2
ICD-10 Finland
Dental examination
1.8
6.8
171
1197
XF600
NOMESCO Finland
Bloodpressure measurement
3.2
6.7
26
84
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
6.7
32
117
M65.3
ICD-10 Finland
Trigger finger
6.6
6.7
16
25
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.1
6.7
18
45
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.2
6.7
59
290
S22.3
ICD-10 Finland
Fracture of rib
2.8
6.7
33
123
E66.9
ICD-10 Finland
Obesity, unspecified
3.7
6.7
21
59
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.4
6.7
24
74
A01
ICPC
Pain general/multiple sites
2.7
6.7
37
147
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
6.7
56
270
A10BA02
ATC
metformin; oral
1.8
6.6
114
711
R06AX27
ATC
desloratadine; oral
1.8
6.6
113
703
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.9
6.6
91
528
R52.9
ICD-10 Finland
Pain, unspecified
2.6
6.6
39
160
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.4
6.5
16
26
WVA20
NOMESCO Finland
Medicine administration
5.9
6.5
17
30
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
6.5
65
336
Z3226
NOMESCO Finland
Physiotherapist
2.1
6.5
69
365
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
6.5
26
86
N05CF01
ATC
zopiclone; oral
1.8
6.5
130
850
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
6.5
87
501
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
14.6
6.4
10
7
D07AB08
ATC
desonide; topical
2.3
6.4
51
240
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.7
6.4
20
56
A07EC01
ATC
sulfasalazine; oral, rectal
2.7
6.4
35
138
J01CA04
ATC
amoxicillin; systemic
1.9
6.4
318
2681
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
6.4
91
534
J01AA02
ATC
doxycycline; systemic
1.8
6.4
300
2485
L03
ICPC
Low back symptom/complaint
1.9
6.4
98
590
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.8
6.3
31
115
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
11.3
6.3
11
10
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
6.3
158
1098
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
6.3
109
680
R74
ICPC
Upper respiratory infection acute
1.8
6.3
117
746
S21
ICPC
Skin texture symptom/complaint
2.2
6.3
58
290
D02
ICPC
Abdominal pain epigastric
3.0
6.3
27
93
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
6.3
175
1252
M01AE02
ATC
naproxen; oral, rectal
1.7
6.3
217
1646
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
6.2
101
617
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.6
6.2
36
146
L04AA13
ATC
[U] leflunomide
5.9
6.2
16
28
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.9
6.2
18
48
A02BA02
ATC
ranitidine; systemic
2.0
6.2
79
447
M03BX02
ATC
tizanidine; oral
1.7
6.1
235
1827
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
6.1
81
463
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.0
6.1
76
425
Z3231
NOMESCO Finland
Registered nurse
1.8
6.1
109
686
ZX120
NOMESCO Finland
Intravenous
2.4
6.1
41
179
JN4AD
NOMESCO Finland
Body CT examination
2.4
6.1
43
192
SPAT1260
SPAT
Consultation of another employee
2.0
6.1
72
396
ZXA10
NOMESCO Finland
Bilateral
2.0
6.1
74
411
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.1
6.1
25
84
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
6.1
234
1820
R03BA02
ATC
budesonide; inhalant
2.0
6.0
76
427
A02BC03
ATC
lansoprazole; oral
1.8
6.0
112
713
L86
ICPC
Back syndrome with radiating pain
3.0
6.0
26
90
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.8
6.0
103
640
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
57
92
7.06
34.88
1.4
1.6
0.19
0.14
iu/ml
0.10
19
17
58
110
6.00
30.16
1.2
1.1
3.32
2.55
u/ml
—
5
11
50
86
6.50
28.65
1.8
1.6
—
—
—
0
0
289
1749
3.37
26.78
13.0
9.5
4.38
4.11
e9/l
1.22
269
1529
247
1381
3.07
26.02
10.1
5.7
2.83
2.81
%
0.06
236
1286
162
717
3.12
26.01
3.2
2.6
352.43
8349.31
umol/l
3.76
140
622
248
1399
3.04
25.54
9.8
5.6
57.27
57.28
%
0.00
237
1309
250
1425
3.02
25.10
10.2
5.8
28.35
28.06
%
0.16
238
1334
255
1489
2.97
24.13
8.4
6.8
1.21
1.21
mmol/l
0.47
226
1245
231
1306
2.83
22.78
6.1
4.6
34.17
35.63
g/l
3.26
216
1216
257
1566
2.80
21.40
7.7
6.4
9.64
11.39
umol/l
3.39
247
1481
169
841
2.75
20.95
2.4
2.0
134.09
237.26
u/l
1.65
164
779
334
2392
3.43
19.75
12.1
7.2
77.91
78.49
u/l
0.10
323
2234
191
1044
2.59
19.18
4.4
2.9
—
—
—
0
0
320
2276
3.05
18.33
7.8
3.6
17.93
12.22
mm/h
6.60
305
2079
223
1347
2.49
17.63
6.9
6.0
1.21
1.22
mmol/l
0.14
216
1218
170
931
2.44
16.38
4.4
2.4
105.55
68.90
u/l
0.51
161
854
221
1364
2.39
16.18
22.2
14.2
1.29
1.26
inr
0.13
53
412
107
478
2.69
15.75
1.4
1.2
38.05
38.04
iu/ml
0.00
30
159
222
1395
2.33
15.29
2.9
2.6
—
—
—
0
0
36
82
4.73
15.05
2.5
2.9
—
—
—
0
0
152
818
2.39
14.95
3.4
2.8
0.25
0.51
e6/l
1.62
128
622
100
445
2.66
14.74
1.5
1.2
14.92
14.43
u/ml
0.02
35
166
63
220
3.21
14.42
2.2
3.0
65.68
67.06
g/l
0.60
56
202
201
1258
2.20
13.41
3.0
2.2
75.17
77.48
nmol/l
0.62
186
1133
121
614
2.39
13.36
3.1
2.3
4.55
6.98
e6/l
1.00
109
551
26
51
5.38
12.86
1.1
1.2
—
—
—
0
0
120
624
2.32
12.41
1.9
1.6
0.77
1.21
mg/l
2.82
100
477
253
1767
2.18
12.39
5.6
4.7
7.06
6.70
mmol/l
1.51
246
1637
159
935
2.16
12.11
3.3
2.9
6.81
7.56
mmol/l
1.49
130
794
85
382
2.56
12.09
2.8
2.5
20.14
23.40
%
1.08
72
323
190
1200
2.11
11.99
2.3
1.9
95.36
96.32
pmol/l
0.10
118
601
163
973
2.14
11.90
3.5
3.2
30.30
30.64
u/l
0.07
158
932
171
1052
2.09
11.43
3.2
3.6
2.34
2.36
mmol/l
1.29
160
941
180
1129
2.08
11.42
4.3
3.4
37.01
40.57
ng/l
0.09
127
765
54
199
2.98
11.20
1.9
1.7
—
—
—
0
0
156
938
2.09
10.99
4.3
3.6
9.09
8.44
mg/mmol
0.06
101
575
219
1494
2.03
10.85
6.0
3.6
0.00
0.01
estimate
0.50
49
305
62
251
2.74
10.81
2.3
1.8
323.40
379.37
nmol/l
1.63
57
229
98
493
2.31
10.78
2.3
2.5
1.34
1.10
e6/l
0.25
67
287
34
96
3.78
10.73
2.8
2.1
—
—
—
0
0
65
272
2.66
10.62
3.7
2.0
30.36
39.77
u/l
0.85
55
239
199
1345
1.96
9.79
3.7
2.7
130.89
122.28
ug/l
0.21
188
1224
90
454
2.27
9.75
1.9
1.8
—
—
—
0
0
16
12
13.83
9.75
1.6
3.8
1898.25
740.92
u/ml
0.56
16
12
89
451
2.25
9.52
3.4
2.7
3.42
2.63
e6/l
0.33
60
248
215
1504
1.93
9.42
7.4
4.8
0.00
0.00
estimate
0.50
49
286
216
1519
1.92
9.26
6.1
3.5
0.00
0.00
estimate
-0.00
49
276
70
324
2.41
9.21
3.5
2.8
4.96
7.54
umol/l
2.56
64
284
123
717
2.03
9.13
3.2
2.0
3.35
3.15
mg/l
0.34
113
597
97
531
2.09
8.46
2.0
1.7
1169.83
1231.12
nmol/l
0.30
86
387
131
800
1.95
8.41
6.9
4.0
0.00
0.00
estimate
0.50
47
277
27
77
3.69
8.40
1.7
1.1
—
—
—
0
0
45
177
2.74
8.25
1.2
1.2
84.50
323.85
u/ml
1.07
39
162
350
2983
2.41
7.95
5.8
4.5
1.93
1.94
mu/l
0.09
334
2691
131
814
1.91
7.91
3.2
3.1
1426.86
1496.64
ng/l
0.06
117
684
41
158
2.78
7.81
4.0
3.3
1.46
1.94
mmol/l
0.35
28
116
366
3192
2.77
7.76
27.3
12.6
22.39
24.16
mg/l
0.50
328
2443
305
2476
1.98
7.75
4.7
3.8
15.01
14.73
pmol/l
1.19
290
2215
109
643
1.96
7.65
1.4
1.2
0.91
2.09
u/ml
0.88
38
171
173
1191
1.80
7.43
6.2
3.8
—
—
—
0
0
92
519
2.00
7.31
1.7
1.5
—
—
—
0
0
265
2077
1.82
7.25
3.9
2.9
50.94
48.97
u/l
0.15
253
1931
27
86
3.29
7.13
1.3
1.1
—
—
—
0
0
27
86
3.29
7.13
1.3
1.1
—
—
—
0
0
107
644
1.90
7.01
6.5
3.9
1.02
1.02
kg/l
0.07
17
92
114
710
1.85
6.67
2.7
2.3
—
—
—
0
0
22
64
3.58
6.66
2.2
1.6
—
—
—
0
0
22
64
3.58
6.66
1.5
1.5
—
—
—
0
0
32
119
2.84
6.51
1.5
1.7
1.41
1.55
g/l
0.43
27
103
372
3326
2.75
6.45
26.3
14.6
139.65
139.73
mmol/l
0.23
367
3220
373
3341
2.79
6.41
26.6
14.7
3.95
3.95
mmol/l
0.15
368
3226
62
319
2.12
6.26
6.5
9.1
1.26
1.61
mmol/l
0.41
54
263
20
57
3.64
6.24
1.7
1.5
—
—
—
0
0
56
278
2.18
6.19
3.2
3.3
5.68
5.71
kpa
0.09
56
269
38
159
2.54
6.17
1.7
1.4
—
—
—
0
0
16
39
4.23
6.14
1.4
1.1
—
—
—
0
0
23
73
3.28
6.12
1.6
1.8
18.96
1175.22
u/l
—
9
24
95
577
1.85
5.96
2.8
2.8
2.46
2.45
mmol/l
0.31
87
516
59
305
2.10
5.88
1.7
1.8
—
—
—
0
0
59
306
2.09
5.83
1.7
1.8
—
—
—
0
0
20
60
3.46
5.80
2.0
1.8
10937.93
21370.00
e6/l
0.51
14
48
36
152
2.50
5.74
1.3
1.3
—
—
—
0
0
38
166
2.42
5.64
4.5
2.4
0.25
0.25
e6/l
0.00
38
159
40
179
2.37
5.64
2.6
2.4
—
32.17
—
0
11
341
2982
1.99
5.59
8.1
5.3
41.67
39.62
mmol/mol
3.35
327
2750
21
69
3.16
5.30
1.4
1.7
—
—
—
0
0
47
232
2.16
5.27
3.0
2.7
4.17
4.58
kpa
0.90
47
222
85
517
1.82
5.26
4.6
3.6
35.05
303.30
ng/l
2.78
64
401
243
1954
1.62
5.15
2.9
2.9
—
—
—
0
0
103
668
1.73
5.11
1.9
1.7
465.60
436.24
pmol/l
0.43
89
563
19
61
3.22
4.98
1.8
1.4
—
—
—
0
0
17
51
3.44
4.94
3.4
3.0
4.02
4.13
e9/l
0.09
17
51
47
240
2.09
4.84
3.1
3.2
82.39
81.07
ng/l
0.03
40
211
377
3465
2.60
4.82
18.2
9.6
26.68
25.14
u/l
1.03
371
3320
20
68
3.04
4.78
1.2
1.4
—
—
—
0
0
34
154
2.32
4.68
1.7
1.7
—
—
—
0
0
10
14
7.29
4.68
1.2
1.9
13.20
15.07
%
—
10
14
15
43
3.59
4.66
1.2
1.6
104.17
107.63
u/ml
—
6
8
11
20
5.62
4.32
1.6
1.1
—
—
—
0
0
11
20
5.62
4.32
1.6
1.1
—
—
—
0
0
11
20
5.62
4.32
1.6
1.1
—
—
—
0
0
11
20
5.62
4.32
1.6
1.1
—
—
—
0
0
11
20
5.62
4.32
1.6
1.1
—
—
—
0
0
17
56
3.13
4.29
3.4
3.2
56.94
57.04
%
0.01
17
56
16
51
3.23
4.25
1.1
1.2
155.45
259.30
u/ml
1.28
11
30
17
57
3.07
4.17
1.1
1.2
—
—
—
0
0
31
145
2.23
3.98
2.3
2.4
0.74
0.69
%
0.28
31
145
343
3089
1.79
3.98
21.5
11.7
79.77
81.02
ml/min/173m2
0.50
314
2514
13
32
4.16
3.93
2.0
1.5
—
—
—
0
0
13
32
4.16
3.93
2.0
1.5
—
—
—
0
0
13
32
4.16
3.93
2.0
1.5
—
—
—
0
0
27
120
2.34
3.90
1.7
1.9
—
—
—
0
0
13
33
4.04
3.83
2.0
1.5
—
—
—
0
0
13
33
4.04
3.83
2.0
1.5
—
—
—
0
0
13
33
4.04
3.83
2.0
1.5
—
—
—
0
0
17
62
2.82
3.63
3.4
2.1
131.10
134.59
g/l
—
10
46
8
13
6.25
3.51
1.9
1.9
56.41
61.95
ug/l
—
8
13
18
71
2.61
3.34
1.1
1.3
—
—
—
0
0
6
7
8.68
3.27
1.0
2.1
17.67
29.43
%
—
6
7
53
323
1.74
3.23
4.5
3.3
—
—
—
0
0
8
15
5.42
3.20
1.3
2.0
—
—
—
0
0
98
708
1.51
2.99
1.8
1.4
18.84
20.76
nmol/l
0.68
91
597
8
17
4.78
2.93
1.1
1.1
—
—
—
0
0
6
9
6.75
2.87
1.0
1.0
—
—
—
0
0
8
18
4.51
2.81
1.0
2.2
103.87
93.72
%
—
8
18
345
3182
1.62
2.79
5.8
4.2
6.23
5.90
mmol/l
3.41
330
2881
9
23
3.98
2.79
1.0
1.1
—
—
—
0
0
7
14
5.07
2.74
2.1
1.4
—
—
—
0
0
7
14
5.07
2.74
2.1
1.4
—
—
—
0
0
113
854
1.45
2.74
1.7
1.6
1.51
1.39
mmol/l
0.75
101
704
23
112
2.12
2.73
1.6
1.8
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
10
6.07
2.70
1.0
1.0
99.67
110.30
%
—
6
10
11
35
3.20
2.66
2.7
2.7
—
—
—
0
0
382
3636
2.19
2.66
36.9
18.7
39.27
40.12
%
1.78
358
3398
13
49
2.71
2.65
1.0
1.1
1.00
25.10
iu/ml
—
5
10
12
41
2.99
2.64
1.1
1.0
—
—
—
0
0
12
41
2.99
2.64
2.2
1.3
—
—
—
0
0
9
25
3.66
2.59
2.8
3.7
—
—
—
0
0
382
3641
2.15
2.56
37.4
18.7
4.38
4.48
e12/l
2.94
375
3523
40
242
1.73
2.52
2.8
2.2
4.36
7.32
ug/l
0.94
34
205
352
3285
1.61
2.44
5.6
4.7
2.63
2.82
mmol/l
3.08
337
3016
55
368
1.57
2.37
10.4
6.7
—
—
—
0
0
6
13
4.67
2.28
2.3
1.4
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
13
4.67
2.28
1.0
3.2
163.33
113.69
%
—
6
13
6
13
4.67
2.28
2.3
1.4
—
—
—
0
0
345
3219
1.53
2.23
5.1
4.3
4.51
4.75
mmol/l
3.97
330
2978
11
41
2.73
2.22
1.1
1.0
—
—
—
0
0
333
3092
1.47
2.13
4.6
3.8
1.45
1.27
mmol/l
3.39
317
2833
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
89
2.07
2.09
2.7
2.5
0.28
0.35
u/ml
0.52
13
50
342
3198
1.49
2.05
5.0
4.2
1.37
1.51
mmol/l
7.33
327
2941
18
91
2.02
1.98
1.6
1.6
—
—
—
0
0
8
27
3.00
1.94
1.6
1.8
—
—
—
0
0
8
27
3.00
1.94
1.6
1.8
—
—
—
0
0
8
27
3.00
1.94
1.6
1.8
—
—
—
0
0
8
28
2.89
1.87
2.3
2.0
—
—
—
0
0
16
80
2.04
1.82
1.4
1.3
—
—
—
0
0
8
29
2.79
1.80
2.3
2.0
—
—
—
0
0
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
49
349
1.46
1.61
1.6
1.8
1.55
1.46
%
0.37
42
302
18
309
0.56
1.61
1.7
1.7
—
—
—
0
0
35
237
1.52
1.48
6.5
2.9
64.75
61.34
ml/min/173m2
0.15
16
98
7
28
2.53
1.46
1.6
1.1
—
—
—
0
0
5
16
3.15
1.44
4.8
3.6
—
—
—
0
0
5
16
3.15
1.44
1.4
1.8
—
—
—
0
0
5
16
3.15
1.44
1.4
1.8
—
—
—
0
0
5
16
3.15
1.44
3.0
5.0
64.80
114.69
nmol/l
—
5
16
17
96
1.81
1.41
1.5
1.4
140.83
243.26
miu/ml
—
8
48
8
34
2.38
1.30
1.6
1.3
—
—
—
0
0
5
18
2.80
1.29
1.2
1.2
—
—
—
0
0
46
343
1.39
1.21
4.1
4.3
3.12
41.36
ug/l
0.98
39
281
11
58
1.92
1.13
1.4
1.1
—
—
—
0
0
11
58
1.92
1.13
1.4
1.1
—
—
—
0
0
10
51
1.99
1.12
2.0
2.6
107.10
105.37
mmol/l
—
10
51
7
33
2.14
1.06
1.9
2.2
—
—
—
0
0
9
46
1.98
1.04
1.0
1.1
—
—
—
0
0
13
75
1.76
1.04
1.5
1.7
—
—
—
0
0
7
34
2.08
1.03
1.0
1.1
—
—
—
0
0
10
54
1.87
0.97
2.1
1.8
—
—
—
0
0
20
133
1.53
0.96
2.3
1.9
—
—
—
0
0
10
55
1.84
0.93
1.6
1.7
—
—
—
0
0
10
55
1.84
0.93
1.6
1.7
—
—
—
0
0
23
162
1.45
0.86
2.3
1.9
—
—
—
0
0
92
793
1.21
0.83
4.3
4.7
1.53
2.50
ug/l
1.50
83
700
6
32
1.89
0.82
1.2
1.5
—
—
—
0
0
8
47
1.72
0.81
1.3
1.5
—
—
—
0
0
8
47
1.72
0.81
1.5
1.5
—
—
—
0
0
15
98
1.55
0.79
1.7
1.4
—
—
—
0
0
5
25
2.01
0.73
1.2
1.2
—
—
—
0
0
20
144
1.41
0.69
1.1
1.0
—
—
—
0
0
25
188
1.35
0.68
2.2
2.7
150.28
54.41
u/ml
0.49
25
181
7
43
1.64
0.67
1.1
1.7
—
—
—
0
0
15
104
1.46
0.63
1.2
1.7
—
—
—
0
0
8
53
1.52
0.58
1.5
1.6
—
—
—
0
0
6
39
1.55
0.53
1.5
1.7
—
—
—
0
0
6
39
1.55
0.53
1.5
1.7
—
—
—
0
0
6
39
1.55
0.53
1.2
1.7
—
—
—
0
0
53
457
1.18
0.50
2.5
3.0
0.59
0.77
ug/l
1.54
37
296
10
67
1.51
0.50
1.3
1.2
—
—
—
0
0
7
45
1.57
0.49
1.4
1.6
—
—
—
0
0
5
31
1.62
0.43
1.2
1.4
—
—
—
0
0
5
33
1.52
0.41
1.4
1.3
—
—
—
0
0
27
223
1.23
0.41
1.1
1.2
57.97
141.17
iu/ml
—
9
95
71
639
1.14
0.40
3.5
4.3
24.36
20.86
%
1.16
30
294
35
298
1.19
0.40
2.1
2.1
—
—
—
0
0
10
71
1.42
0.39
2.7
1.7
—
—
—
0
0
10
71
1.42
0.39
1.6
1.6
—
—
—
0
0
60
535
1.14
0.39
1.4
1.4
—
—
—
0
0
9
66
1.37
0.38
2.8
1.6
43.44
39.39
nmol/l
—
9
66
5
36
1.39
0.38
1.4
1.6
—
—
—
0
0
8
113
0.70
0.37
1.3
1.5
—
—
—
0
0
10
74
1.36
0.32
2.7
2.4
47.24
69.00
ug/min
—
5
42
31
267
1.17
0.32
2.0
2.0
—
—
—
0
0
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
8
67
1.20
0.26
1.0
1.0
—
—
—
0
0
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
41
383
1.08
0.14
5.4
4.3
31.35
31.63
%
0.06
34
254
12
127
0.94
0.01
1.2
1.5
—
—
—
0
0
14
133
1.05
0.01
1.6
1.9
5.31
7.62
mg/l
0.23
14
98
0
8
0.00
0.00
0.0
1.0
—
20.34
—
0
8
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
5
49
1.02
-0.00
1.4
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
70.10
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_PANNICULITISNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PANNICULITISNAS | 1.38 [1.15, 1.66] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.527 |
During the follow-up period (1.1.1998 — 31.12.2019), 280 out of 1244 females with M13_PANNICULITISNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PANNICULITISNAS | 1.738 [1.29, 2.34] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 139 out of 552 males with M13_PANNICULITISNAS died.
Mortality risk
Mortality risk for people of age
years, who have M13_PANNICULITISNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.178% | 0.309% |
| 5 | 0.897% | 1.926% |
| 10 | 2.107% | 4.525% |
| 15 | 4.121% | 8.675% |
| 20 | 7.064% | 14.637% |
Relationships between endpoints
↥Index endpoint: M13_PANNICULITISNAS – Panniculitis, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data